SANEMUS elaborates concept for strategic redirection of a German pharmaceutical company

The SANEMUS team supports a German mid-sized pharmaceutical company for its strategic redirection. The focus lies on the elaboration of strategic options for an expansion of its business to ensure a sustainable growth in the future. Portfolio optimization, in and out licensing of products as well as the optimal marketing and sales support of the new portfolio are the main issues of the strategic redirection.